论文部分内容阅读
特发性血小板减少性紫癜(ITP)世界各国均有发生,但治疗效果并不甚满意。基于ITP与自身免疫有关的认识,我们采用自行设计的VLAP[长春新碱(VCR)、左旋咪唑、氨肽素、强的松]方案治疗该病,取得良好效果,现介绍如下。资料与方法VLAP治疗组40例:男7例、女
Idiopathic thrombocytopenic purpura (ITP) occurred in all countries in the world, but the treatment effect is not very satisfactory. Based on the ITP and autoimmune-related understanding, we have adopted the VLV [vincristine (VCR), levamisole, aminopeptidase, prednisone] designed to treat the disease, and achieved good results, are presented below. Materials and Methods VLAP treatment group of 40 patients: 7 males and females